Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gut Research Advancing a Mechanistic and Personalised Understanding of Symptoms in Cystic Fibrosis: The GRAMPUS-CF Strategic Research Centre

NCT05934656 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.

NCT NCT05934656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05934656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gut Research Advancing a Mechanistic and Personalised Understanding of Symptoms in Cystic Fibrosis: The GRAMPUS-CF Strategic Research Centre
Lead sponsor
University of Nottingham
Phase
Observational
Overall status
Unknown status
Start date
June 26, 2023
Completion date
March 31, 2026
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis, gastrointestinal dysfunction